To assess cerebral energetics in transgenic mouse models of neurologic disease, a robust, efficient, and practical method for quantification of cerebral oxygen consumption is needed.
INTRODUCTION
Despite its relatively small size (B2% of body weight), the brain consumes B20% of all oxygen used in the body. Impairments in the ability of mitochondria to fuel brain function are implicated in many neurodegenerative diseases. 1 However, in vivo confirmation of mitochondrial dysfunction in these diseases is largely lacking.
Techniques to assess cerebral energetics in vivo include 13 C magnetic resonance spectroscopy (MRS), 2 31 P MRS, 3 and positron emission tomography. 4 13 C magnetic resonance spectroscopy bears substantial challenges for studies in the mouse, including the need to place arterial and venous catheters, which precludes longitudinal measurements, and the small blood volume of mice, which precludes blood draws in the scanner (needed for proper analysis of the data).
31 P magnetization transfer MRS yields ATP metabolism rates, however, requires long data acquisition times in the mouse brain because of low sensitivity.
18 F-fluorodeoxyglucose positron emission tomography imaging can assess hypometabolism in neurologic diseases, 4 however, involves repeated radiation exposure in longitudinal studies. 15 O positron emission tomography has been used to image cerebral oxygen utilization rate in the human brain; 5 however, it is difficult to map cerebral metabolic rate of oxygen (CMRO 2 ) in mouse brain by this method because of limited spatial resolution. In addition, the 15 O radioactive tracer has very short half-life (B2 minutes), thus, requires on-site tracer generation. Therefore, a robust and practical method that can directly quantify cerebral oxygen consumption and that can be applied repeatedly in transgenic mouse models of neurologic disease is highly needed to address the involvement of cerebral energetics in these diseases. 17 O MRS imaging (MRSI) can be utilized to map CMRO 2 , 6 and has been rigorously validated in rat brains 7 and applied to small animal models including healthy cats 8 6 Thereby the methodology produces three-dimensional maps of CMRO 2 quickly and reliably. However, mice present unique challenges for 17 O MRSI because of their small size. First, oral intubation, which has been essential for controlled 17 O gas delivery in rats and cats, is substantially more challenging in mice. Mouse intubations are feasible, 10 however, require extensive training and practice, making the measurements dependent on an individual skilled in this procedure and preventing practical and routine applicability of the method. Second, minimization of the dead space between the 17 O reservoir and the mouse is required for rapid gas switching and to limit the use of the expensive 17 O 2 gas (currently B$3,000 for 1 L of 70% enriched gas). One study demonstrated the feasibility of 17 O MRSI at 11.7T in stroke mice, 9 where each mouse serves as their own control and CMRO 2 can be compared bilaterally. Critically, the detection sensitivity for the H 2 17 O signal increases in a supra-linear fashion with increasing magnetic field. 6, 11 Here, our goal was to develop robust, efficient, and practical methodology to measure regional CMRO 2 in the mouse brain at 16.4T and to assess the reproducibility of the measurements.
MATERIALS AND METHODS Subjects
All animal experiments were approved by the University of Minnesota Institutional Animal Care and Use Committee and performed according to the National Research Council's Guide for the Care and Use of Laboratory Animals. Five healthy male mice on FVB (N ¼ 2, age 20 to 25 weeks; weight 35 to 40 g) and C57B6/CBA (N ¼ 3, 7 to 10 weeks; 27 to 30 g) backgrounds were used.
Animal Preparation
Animals were induced with 3% to 4% isoflurane and a 1:1 mixture of O 2 :N 2 O. Spontaneously breathing mice were fixed in a custom built mouse holder/nose cone system and maintained anesthetized with 1.2% to 2% isoflurane while monitoring body temperature and respiration rate (SA Instruments, Stony Brook, NY, USA) during MR scanning. Body temperature was maintained at B371C with a circulating warm water system and a heating fan system.
In addition, a MouseOx Plus (Starr Life Sciences, Oakmont, PA, USA) system was used to monitor heart rate, oxygen saturation, breathing rate, and pulse distension when testing the 17 O gas delivery system outside the scanner.
Gas Delivery System
A custom, switchable, magnet-compatible gas delivery system was developed to provide 17 O 2 to the anesthetized mouse ( Figure 1 ). The mouse's nose was held in place through a flexible membrane into a conical nose cone by an o-ring. The nose cone had an exhaust port vented to the outside and an input port connected to the common port of a manually controlled three-way, pneumatic balloon valve (Hans Rudolph, Shawnee, KS, USA). Pressure (9 psi) for the balloon valve was stepped down from house air. The normally open balloon valve port provided N 2 O/O 2 / isoflurane gas from a mixing valve and vaporizer to the nose cone. The N 2 O/ 17 O 2 /isoflurane gas mixture was loaded into one side of a custom designed non-diffusible, flexible 250 mL double compartment gas reservoir (Hans Rudolph) and the composition of the gas mixture was ascertained with a capnometer (Capnomac Ultima, ULT-SVI, Datex, Helsinki, Finland). The output port of the reservoir was connected to the alternate input port of the balloon valve. To expel the 17 O gas mixture, the back side of the gas reservoir was filled with air. Programmable solenoid valves (ValveBank8, Automate Scientific, Berkeley, CA, USA) gated the flow of low pressure air (9 psi) to fill the back reservoir and vent the normal O 2 mixture to the exhaust stream. Timing of the manually switched balloon valve was also triggered by the ValveBank8. The balloon valve and the gas reservoir were positioned as close to the mouse as possible to minimize dead space and speed the delivery of the 17 O 2 gas mixture. The balloon valve was positioned inside the magnet bore with the pneumatic switch extending into the surrounding control room. The gas reservoir was kept inside the scanner bore or positioned just outside the bore if refilling was needed during the scanning session.
Magnetic Resonance Protocol
All MRI studies were performed using a 16. 4 inhalation period was applied and the slopes were used for calculating the CMRO 2 values. This simplified model has been previously validated in rat brains with short 17 O 2 inhalation where fast exchange of the oxygen gas is expected. 7, 12 Similarly, this completely non-invasive CMRO 2 quantification method was applied to mouse model in the present study.
RESULTS
The newly designed gas delivery system (Figure 1 ) was tested on the bench and inside the scanner to ensure that there were no gas leaks. No changes were observed in the mouse heart rate, oxygen saturation, breathing rate, and pulse distension during the switch to the 17 O gas reservoir. The system ensured efficient gas delivery, with B100 to 120 mL 17 O 2 (70% enriched) required per 2.5-minute inhalation period with enriched gas.
For CMRO 2 measurements, the 17 O/ 1 H coil was set up such that oxygen utilization could be measured with high sensitivity in a volume encompassing the striatum, a structure of high interest for various neurodegenerative diseases. At a nominal voxel size of 9.3 mm 3 (diameter of 2.2 mm and height of 2.4 mm for the cylindrical voxel) and a temporal resolution of 15.4 seconds, the signal-to-noise ratio of the 17 O MRSI data were sufficient for reliable CMRO 2 measurements in the sensitive area of the coil (Figure 2A) . Figure 2B ). The oxygen consumption rate was calculated from linear fits to the slopes of rising H 2 17 O levels during the inhalations (Figures 2C and 2D ). An average striatal oxygen consumption rate of 2.6 ± 0.4 (SD) mmol/g per minute (N ¼ 28) was calculated from 14 bilateral voxels of five healthy mice (two scanned twice). Mice were stable physiologically during all sessions, as illustrated by their spontaneous Figure 2F ) and a CV of 5% from the striatal voxel.
DISCUSSION
Here we demonstrated that efficient and practical 17 O MRS measurements of CMRO 2 in the mouse brain are feasible with high sensitivity and reproducibility using 16.4T, a surface 1 H/ 17 O coil and a newly designed gas delivery system. The method has numerous potential applications to mouse models of human diseases because there is substantial interest in 'tweaking' energy metabolism to prevent and treat neurologic disorders 13 and because such treatments are almost always tested in mouse models first. 14 9 the issue of efficient gas delivery was not addressed previously. The current study aimed to move the methodology to routine use by optimizing efficient delivery of the expensive 17 O 2 gas. Namely, normal tidal volumes are B0.25 mL in mice. The 200 to 250 mL of N 2 O/ 17 O 2 /isoflurane gas mixture flowing during a 2.5-min inhalation provides sufficient airflow to sustain normal respiration without compromising breathing rates or producing rebreathing and results in a per inhalation cost of B$350 for 17 O gas. In addition, a higher field scanner was utilized in the current study relative to the prior study, 9 enabling a higher spatial resolution (9.3 versus 15 mL nominal), which was sufficient to localize, e.g. the striatum. Note, however, that this was not a strict comparison of the 17 O sensitivities at the two fields, which is best accomplished by utilizing the same set-up (coil/phantom/animal) at both fields. 11 In this pilot study, we utilized two different background strains and mice at different ages to make sure that the O 2 delivery system worked with different sized mice and to include any biological variability due to these variables within the measurements. To tease out specific effects of age and strain, a larger and more systematic study should be performed.
The mean striatal CMRO 2 obtained here was higher than previously reported CMRO 2 in anesthetized rat brain, 7 which is expected, as metabolic rates are higher in mice than rats. In addition, the oxygen utilization rate obtained here was consistent with previously reported CMRO 2 in anesthetized mouse brain. 9 Finally, the excellent reproducibility demonstrated in this study (5% to 7% within-session test-retest CV) indicates that this method can be applied in the future to test responses to physiologic challenges in individual mice.
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